Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||
Goods sale service render cash | 7.45%90.09B | 1.92%393.91B | 2.26%275.85B | 0.47%179.38B | -1.94%83.84B | 6.11%386.49B | 5.59%269.74B | 8.32%178.55B | 11.91%85.5B | 3.44%364.22B |
Refunds of taxes and levies | -60.16%35.62M | -54.57%212.73M | -25.87%205.5M | -42.15%142.17M | --89.4M | -38.49%468.22M | -48.45%277.22M | -32.69%245.73M | --0 | 201.57%761.18M |
Cash received relating to other operating activities | -37.69%1.29B | 8.77%5.35B | 33.56%5.01B | 61.62%2.51B | 95.30%2.07B | 32.76%4.92B | 77.71%3.75B | 12.25%1.56B | -2.32%1.06B | 24.61%3.71B |
Cash inflows from operating activities | 6.30%91.42B | 1.94%399.48B | 2.66%281.07B | 0.94%182.04B | -0.65%86B | 6.29%391.87B | 6.06%273.77B | 8.26%180.35B | 11.71%86.56B | 3.76%368.68B |
Goods services cash paid | 15.54%64.71B | 6.51%222B | 10.24%166.24B | 11.05%115.05B | 13.31%56.01B | 10.49%208.43B | 15.59%150.79B | 19.32%103.6B | 10.46%49.43B | 11.96%188.65B |
Staff behalf paid | -1.48%15.43B | 5.45%66.89B | -3.48%42.49B | -4.92%28.33B | -3.52%15.67B | 3.49%63.43B | 0.42%44.02B | -1.72%29.8B | 1.92%16.24B | 7.91%61.29B |
All taxes paid | 36.83%2B | 21.30%12.36B | 25.79%9.14B | -3.08%5.38B | -6.27%1.46B | 0.50%10.19B | 2.25%7.27B | 13.62%5.55B | 20.26%1.56B | -20.19%10.14B |
Cash paid relating to other operating activities | -28.91%1.42B | 27.27%6.97B | 23.89%4.95B | 45.20%3.14B | 1.52%2B | -20.57%5.48B | -3.09%3.99B | 25.77%2.16B | 60.68%1.97B | 28.45%6.9B |
Cash outflows from operating activities | 11.23%83.57B | 7.20%308.22B | 8.13%222.82B | 7.64%151.9B | 8.58%75.14B | 7.70%287.53B | 11.08%206.07B | 14.03%141.11B | 9.48%69.2B | 9.70%266.97B |
Net cash flows from operating activities | -27.78%7.85B | -12.54%91.26B | -13.96%58.25B | -23.19%30.14B | -37.43%10.86B | 2.59%104.34B | -6.76%67.7B | -8.41%39.24B | 21.60%17.36B | -9.17%101.71B |
Investing cash flow | ||||||||||
Cash received from disposal of investments | 74.78%12.53B | 23.55%23.48B | 101.28%22.69B | 252.87%12.63B | 740.25%7.17B | -34.73%19.01B | -49.85%11.27B | -78.54%3.58B | -85.94%853.02M | -66.60%29.12B |
Cash received from returns on investments | 32.32%53.28M | 19.43%2.45B | 5.31%1.92B | 3.28%1.52B | -36.28%40.26M | 25.04%2.05B | 33.51%1.82B | 17.07%1.47B | 607.04%63.19M | -4.30%1.64B |
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 168.06%363.44M | 41.99%1.97B | 18.55%1.05B | 18.62%750.37M | -61.88%135.58M | -17.90%1.39B | 11.28%885.01M | -17.74%632.58M | 214.85%355.63M | -25.56%1.69B |
Cash received relating to other investing activities | -66.81%1B | 13.59%21.03B | -18.61%12.62B | -1.59%11.42B | 88.48%3.02B | -25.64%18.52B | -23.65%15.5B | 10.48%11.6B | -74.60%1.6B | 25.37%24.9B |
Cash inflows from investing activities | 34.62%13.95B | 19.47%48.94B | 29.83%38.27B | 52.25%26.32B | 260.71%10.36B | -28.58%40.96B | -34.40%29.48B | -40.82%17.29B | -77.00%2.87B | -48.35%57.35B |
Cash paid to acquire fixed assets intangible assets and other long-term assets | -4.87%14.8B | -4.57%75.74B | -2.01%48.91B | -3.40%32.08B | -7.27%15.56B | 9.53%79.37B | 2.14%49.91B | 7.13%33.21B | 11.79%16.78B | 0.58%72.47B |
Cash paid to acquire investments | 1,854.25%7.63B | -76.21%7.23B | -89.63%1.26B | -88.55%942.38M | -85.05%390.21M | 56.82%30.41B | 103.40%12.2B | 265.53%8.23B | 1,589.66%2.61B | -79.60%19.39B |
Net cash paid to acquire subsidiaries and other business units | ---- | --3.9M | --3.9M | --3.9M | ---- | ---- | --0 | ---- | ---- | ---- |
Cash paid relating to other investing activities | -36.67%1.9B | 202.82%50.62B | 105.11%28.1B | 44.48%16.04B | 172.73%3B | -22.68%16.72B | -30.65%13.7B | -20.71%11.1B | -79.25%1.1B | 15.60%21.62B |
Cash outflows from investing activities | 28.38%24.33B | 5.61%133.6B | 3.26%78.28B | -6.61%49.07B | -7.52%18.95B | 11.48%126.5B | 1.59%75.81B | 11.19%52.54B | 0.13%20.49B | -38.93%113.48B |
Net cash flows from investing activities | -20.85%-10.39B | 1.03%-84.66B | 13.65%-40.01B | 35.47%-22.75B | 51.23%-8.59B | -52.40%-85.54B | -56.08%-46.33B | -95.37%-35.26B | -120.84%-17.62B | 24.94%-56.13B |
Financing cash flow | ||||||||||
Cash received from capital contributions | -64.04%2.64M | -94.20%22.39M | -96.07%12.35M | -97.66%7.35M | -47.50%7.35M | -86.90%386.07M | 1,470.33%314.07M | --314.07M | --14M | 28,367.15%2.95B |
-Including: Cash received from capital contributions by minority shareholders of subsidiaries | -64.04%2.64M | -94.20%22.39M | -96.07%12.35M | -97.66%7.35M | -47.50%7.35M | -55.48%386.07M | 1,470.33%314.07M | --314.07M | --14M | 8,279.39%867.27M |
Cash from borrowing | 302.46%246.81M | 15.25%1.49B | 10.15%532.62M | 17.69%374.57M | --61.33M | -77.69%1.29B | -90.48%483.56M | 297.83%318.26M | --0 | -21.51%5.8B |
Cash received relating to other financing activities | --394.93M | -68.53%485.27M | -65.61%867.67M | ---- | ---- | 77.17%1.54B | 127.96%2.52B | -72.93%1.79B | 119.65%2.15B | -21.64%870.37M |
Cash inflows from financing activities | 838.31%644.38M | -37.96%2B | -57.46%1.41B | -84.26%381.92M | -96.83%68.68M | -66.50%3.22B | -46.50%3.32B | -63.83%2.43B | 104.39%2.17B | 12.98%9.62B |
Borrowing repayment | -67.27%67.1M | -80.51%1.16B | -85.62%776.76M | 86.50%538.63M | 161.54%205.02M | -44.06%5.93B | -40.38%5.4B | -96.79%288.81M | -98.86%78.39M | 9.22%10.61B |
Dividend interest payment | -25.51%345.09M | 16.95%12.92B | 13.90%6.74B | 3.49%1.67B | 13.01%463.28M | 26.28%11.04B | 25.01%5.92B | -53.70%1.61B | 7.35%409.96M | -9.70%8.75B |
Cash payments relating to other financing activities | -12.43%3.8B | 8.49%13.84B | 10.55%10.35B | -2.80%7.47B | 23.48%4.34B | -16.19%12.75B | -28.22%9.37B | -13.16%7.69B | -17.97%3.52B | 1.25%15.22B |
Cash outflows from financing activities | -15.88%4.22B | -6.13%27.91B | -13.60%17.87B | 0.95%9.68B | 25.11%5.01B | -14.00%29.73B | -22.94%20.69B | -55.04%9.59B | -65.33%4.01B | 0.42%34.57B |
Net cash flows from financing activities | 27.75%-3.57B | 2.26%-25.91B | 5.22%-16.46B | -29.82%-9.3B | -168.74%-4.94B | -6.24%-26.51B | 15.86%-17.37B | 51.01%-7.16B | 82.47%-1.84B | 3.71%-24.95B |
Net cash flow | ||||||||||
Exchange rate change effecting cash and cash equivalents | 115.30%1.75M | -38.03%64.98M | -137.17%-59.57M | -89.05%22.5M | 100.88%814.99K | -73.72%104.86M | -71.21%160.3M | -4.02%205.42M | -74.30%-92.9M | 610.56%398.97M |
Net increase in cash and cash equivalents | -128.66%-6.11B | -153.31%-19.25B | -58.61%1.72B | 36.50%-1.89B | -21.89%-2.67B | -136.14%-7.6B | -81.78%4.16B | -128.67%-2.98B | 48.40%-2.19B | 87.72%21.03B |
Add:Begin period cash and cash equivalents | -40.33%28.49B | -13.73%47.74B | -13.73%47.74B | -13.73%47.74B | -13.73%47.74B | 61.31%55.34B | 61.31%55.34B | 61.31%55.34B | 61.31%55.34B | 48.49%34.31B |
End period cash equivalent | -50.34%22.38B | -40.33%28.49B | -16.87%49.46B | -12.44%45.85B | -15.20%45.07B | -13.73%47.74B | 4.11%59.5B | 17.16%52.36B | 76.81%53.15B | 61.31%55.34B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- | -- | Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- | -- | Deloitte Huayong Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.